Windtree’s BNB Vision Hits Nasdaq Roadblock What’s Happening? Biotech firm Windtree Therapeutics, which made headlines for its ambitious BNB treasury plans, faces a major setback. The...
Nasdaq Drops Windtree Amid Crypto Downturn What’s Happening? After a failed pivot to digital assets, Windtree Therapeutics is being delisted from Nasdaq. The company’s shares plummeted...
